Detailed Narrative
Q4 FY25 Performance Overview
Somany Ceramics reported a 5% increase in total sales and 3% in volume for Q4 FY25. Operating margins remained largely flat at 8.2%, while gross margins decreased by approximately 2.8%. For the full fiscal year 2025, EBITDA stood at INR221 crores, representing 8.4% of sales, a slight decrease from 89.8% in the previous year. The company noted that the Q4 margin pressure was partly due to extra discounting towards the end of the year.
Capacity Utilization and Max Plant Challenges
Overall capacity utilization for FY25 was 81%, down from 86% last year, with Q4 utilization also at 81% compared to 89% last year. The Max plant, the newest facility, continues to be a drag on consolidated profitability, though other plants remain profitable. Management aims to stabilize the Max plant, which currently operates at 55% capacity utilization, targeting 75-80% within a couple of quarters to achieve profitability. The breakeven utilization for Max plant has been revised to 75% due to a shift towards lower-margin products.
Segmental Performance and Mix
The Bathware segment showed strong growth, with sales increasing by 18% in Q4 and 11% for the full year FY25, a key area of focus for the company. Ceramic PVT and GVT products constituted 33% of the mix in Q4 and 34% for the full year. The company's sales mix for FY25 was 81% from channels, 10% from private projects, and 8.5% from government. In Q4, government sales improved to 9.3% and private projects to 10.5%.
Outlook and Strategic Priorities for FY26
Somany Ceramics is guiding for high single-digit to low double-digit sales growth and an EBITDA margin improvement of 1-1.5% for FY26. The company expects government and private project sales to increase to about 25% of total sales, with channel sales reducing to 75%. Strategic priorities include improving product mix, reducing employee costs as a percentage of sales, and maintaining brand premium over aggressive discounting.
Industry Dynamics and Morbi Challenges
The export market experienced a significant 20% decline in FY25, from INR20,000 crores to INR16,000-17,000 crores, due to external factors. The company acknowledged increased competition from unorganized Morbi players, who have aggressively expanded dealerships, leading to some market share loss at the lower end. However, management anticipates consolidation in the Morbi industry, expecting 70-80 plants to shut down due to financing issues, increased land prices, and taxation complexities, which could benefit organized players.
Capital Structure and Debt
The company's total debt levels stood at INR288 crores, which is an increase from INR233 crores last year (based on the transcript's wording). On a standalone basis, the company reported no debt and no consumption of working capital. For FY26, only routine capex is planned, with a potential small capex for bathware and sanitaryware towards the end of the year.